Literature DB >> 12746947

Non-CF bronchiectasis: clinical and HRCT evaluation.

A B Chang1, J P Masel, N C Boyce, G Wheaton, P J Torzillo.   

Abstract

Childhood bronchiectasis not related to underlying disease is still common in some populations in affluent countries. The aims of the study were to: 1) describe demographics, 2) evaluate the effectiveness of routine investigations, and 3) determine the relationship between spirometry and radiology scoring systems, in children with chronic suppurative lung disease (CSLD) living in Central Australia. Data of children living in Central Australia aged </=15 years with noncystic fibrosis CSLD were identified over 2 years. Chest high-resolution computed tomography (HRCT) scans were interpreted by a pediatric radiologist and scored according to three systems. Sixty-five children were identified, resulting in a prevalence of at least 14.7/1,000 aboriginal children aged </=15 years. Comorbidities (most common: suppurative otitis media in >70%) and early hospitalisation for pneumonia were common (median age, 0.5 years). Previous admissions for pneumonia were almost universally present and significantly more common than bronchiolitis (95% CI for proportional difference, 0.4-0.51). Although the majority did not have a treatable underlying cause, investigations had significant impact on management in 12.3% of children. None of the chest HRCT scores related to any spirometry data. In conclusion, CSLD is unacceptably common in indigenous children of this region, commences early in life, and is associated with significant comorbidities. Spirometry data do not reflect the severity of lung disease in HRCT scans. While improvement in the living standards is of utmost importance, the medical management that includes thorough investigations of these children should not be neglected. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12746947     DOI: 10.1002/ppul.10289

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  36 in total

1.  New Zealand national incidence of bronchiectasis "too high" for a developed country.

Authors:  J Twiss; R Metcalfe; E Edwards; C Byrnes
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

Review 2.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

3.  Approach to chronic cough.

Authors:  Keya Rani Lahiri; Amruta Avinash Landge
Journal:  Indian J Pediatr       Date:  2014-04-22       Impact factor: 1.967

4.  Chronic suppurative lung disease in adults.

Authors:  Mark L Metersky; Antranik Mangardich
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Culture and PCR detection of Haemophilus influenzae and Haemophilus haemolyticus in Australian Indigenous children with bronchiectasis.

Authors:  K M Hare; M J Binks; K Grimwood; A B Chang; A J Leach; H Smith-Vaughan
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

6.  Evaluation of Noncystic Fibrosis Bronchiectasis Using Clinical and Radiological Scorings in Children.

Authors:  Abdurrahman Erdem Başaran; Ayşen Başaran; İbrahim Cemal Maslak; Gökhan Arslan; Ayşen Bingöl
Journal:  Turk Thorac J       Date:  2018-09-13

7.  Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Authors:  Gregory J Redding; Rosalyn J Singleton; Patricia C Valery; Hayley Williams; Keith Grimwood; Peter S Morris; Paul J Torzillo; Gabrielle B McCallum; Lori Chikoyak; Robert C Holman; Anne B Chang
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

8.  Can a management pathway for chronic cough in children improve clinical outcomes: protocol for a multicentre evaluation.

Authors:  A B Chang; C F Robertson; P P van Asperen; N J Glasgow; I B Masters; C M Mellis; L I Landau; L Teoh; P S Morris
Journal:  Trials       Date:  2010-11-06       Impact factor: 2.279

Review 9.  Pneumococcal vaccines for children and adults with bronchiectasis.

Authors:  Christina C Chang; Rosalyn J Singleton; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

10.  Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Authors:  J Twiss; A W Stewart; C A Byrnes
Journal:  Thorax       Date:  2006-02-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.